Market leader in peptide API manufacturing and services
PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) supporting pharmaceutical and biotech companies in the development and manufacturing of proprietary and generic active pharmaceutical ingredients (API).
Expanding the Reach of Sustainable Solid-Phase Peptide Synthesis
2 Apr 2025 - Alloc protecting group expanded the peptide synthesis toolbox – but its removal has been a problem: toxic solvents, air-sensitive Pd0) reagents, challenging upscaling. Not anymore A […]
Read moreImpurities in Peptide Drug Substance and Challenges Faced during Registration (in US, EU, Brazil and China Markets) and Commercial Phase
20 Mar 2025 - Controlling impurities in complex drug substances is a crucial part of development and due to lack of harmonized approaches from Health authorities, the manufacturer faces many […]
Read more